0 Ratings

ID

12005

Description

Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control; ODM derived from: https://clinicaltrials.gov/show/NCT02493322

Link

https://clinicaltrials.gov/show/NCT02493322

Keywords

  1. 8/31/15 8/31/15 -
Copyright Holder

ODM derived from: https://clinicaltrials.gov/show/NCT02493322

Uploaded on

August 31, 2015

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Essential Arterial Hypertension NCT02493322

    Eligibility Essential Arterial Hypertension NCT02493322

    Inclusion Criteria
    Description

    Inclusion Criteria

    signed consent of the patient;
    Description

    consent

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0514044
    participants with decompensated essential hypertension, classified into stage 1 (with high or very high cardiovascular risk), stage 2 or stage 3 according to the brazilian society of cardiology (2010), who have never been treated and have indication for drug combination treatment.
    Description

    cardiovascular; participants; hypertension; on treatment; combination; indication; stage; never; high; drug; very

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0085580
    obs: the diagnosis may be established by previous evaluation of two blood pressure measures ≥ 140/90 mmhg, with two months difference between measurements
    Description

    blood pressure; diagnosis

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0857121
    Exclusion Criteria
    Description

    Exclusion Criteria

    patients with any clinically significant disease that in the investigator is opinion can not participate in the study;
    Description

    clinically significant; investigator; disease; study

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0012634
    secondary hypertension diagnosis or blood pressure above 190x100 mmhg in the screening/randomization visit;
    Description

    blood pressure; randomization; hypertension; diagnosis; screening; visit

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0155616
    morbid obesity or immunocompromised patients;
    Description

    immunocompromised; obesity

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0085393
    UMLS CUI [2]
    C0028754
    participants with greater than 10 mmhg difference in the measurements of systolic or diastolic blood pressure between the two arms;
    Description

    diastolic blood pressure; participants; systolic; arms

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C3160850
    participants who do not have the two upper limbs;
    Description

    participants; upper

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1140618
    participants with important electrocardiographic changes;
    Description

    participants

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0855329
    creatinine clearance - less than 60 ml /min;
    Description

    creatinine clearance

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0373595
    history of hypertensive emergencies and cardiovascular and / or moderate to severe cerebrovascular events in the past 6 months;
    Description

    cardiovascular; moderate; severe; events

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1561291
    microalbuminuria in urine sample greater than 30 mg/g;
    Description

    microalbuminuria; urine

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0730345
    patients with history of hypersensitivity to any of the formula compounds;
    Description

    history of hypersensitivity to mistletoe

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0020517
    pregnancy or risk of pregnancy and lactating patients;
    Description

    pregnancy

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C2828358
    UMLS CUI [2]
    C0549206
    participation in clinical trial in the year prior to this study.
    Description

    clinical trial; study; year

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0008976

    Similar models

    Eligibility Essential Arterial Hypertension NCT02493322

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    consent
    Item
    signed consent of the patient;
    boolean
    C0514044 (UMLS CUI [1])
    cardiovascular; participants; hypertension; on treatment; combination; indication; stage; never; high; drug; very
    Item
    participants with decompensated essential hypertension, classified into stage 1 (with high or very high cardiovascular risk), stage 2 or stage 3 according to the brazilian society of cardiology (2010), who have never been treated and have indication for drug combination treatment.
    boolean
    C0085580 (UMLS CUI [1])
    blood pressure; diagnosis
    Item
    obs: the diagnosis may be established by previous evaluation of two blood pressure measures ≥ 140/90 mmhg, with two months difference between measurements
    boolean
    C0857121 (UMLS CUI [1])
    clinically significant; investigator; disease; study
    Item
    patients with any clinically significant disease that in the investigator is opinion can not participate in the study;
    boolean
    C0012634 (UMLS CUI [1])
    blood pressure; randomization; hypertension; diagnosis; screening; visit
    Item
    secondary hypertension diagnosis or blood pressure above 190x100 mmhg in the screening/randomization visit;
    boolean
    C0155616 (UMLS CUI [1])
    immunocompromised; obesity
    Item
    morbid obesity or immunocompromised patients;
    boolean
    C0085393 (UMLS CUI [1])
    C0028754 (UMLS CUI [2])
    diastolic blood pressure; participants; systolic; arms
    Item
    participants with greater than 10 mmhg difference in the measurements of systolic or diastolic blood pressure between the two arms;
    boolean
    C3160850 (UMLS CUI [1])
    participants; upper
    Item
    participants who do not have the two upper limbs;
    boolean
    C1140618 (UMLS CUI [1])
    participants
    Item
    participants with important electrocardiographic changes;
    boolean
    C0855329 (UMLS CUI [1])
    creatinine clearance
    Item
    creatinine clearance - less than 60 ml /min;
    boolean
    C0373595 (UMLS CUI [1])
    cardiovascular; moderate; severe; events
    Item
    history of hypertensive emergencies and cardiovascular and / or moderate to severe cerebrovascular events in the past 6 months;
    boolean
    C1561291 (UMLS CUI [1])
    microalbuminuria; urine
    Item
    microalbuminuria in urine sample greater than 30 mg/g;
    boolean
    C0730345 (UMLS CUI [1])
    history of hypersensitivity to mistletoe
    Item
    patients with history of hypersensitivity to any of the formula compounds;
    boolean
    C0020517 (UMLS CUI [1])
    pregnancy
    Item
    pregnancy or risk of pregnancy and lactating patients;
    boolean
    C2828358 (UMLS CUI [1])
    C0549206 (UMLS CUI [2])
    clinical trial; study; year
    Item
    participation in clinical trial in the year prior to this study.
    boolean
    C0008976 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial